Hui‐Lu Zhang
Fudan University(CN)Huashan Hospital(CN)
Publications by Year
Research Areas
Liver Disease Diagnosis and Treatment, Cancer, Hypoxia, and Metabolism, Immune Response and Inflammation, Diabetes and associated disorders, Immune cells in cancer
Most-Cited Works
- → Endotoxin Accumulation Prevents Carcinogen-Induced Apoptosis and Promotes Liver Tumorigenesis in Rodents(2010)345 cited
- → Profound impact of gut homeostasis on chemically-induced pro-tumorigenic inflammation and hepatocarcinogenesis in rats(2012)283 cited
- → Acetyl‐coenzyme A carboxylase alpha promotion of glucose‐mediated fatty acid synthesis enhances survival of hepatocellular carcinoma in mice and patients(2015)146 cited
- → Hepatitis B Virus X (HBx) Induces Tumorigenicity of Hepatic Progenitor Cells in 3,5–Diethoxycarbonyl–1,4–Dihydrocollidine–Treated HBx Transgenic Mice(2011)143 cited
- → OV6+ tumor-initiating cells contribute to tumor progression and invasion in human hepatocellular carcinoma(2012)121 cited
- → p53 promotes inflammation-associated hepatocarcinogenesis by inducing HMGB1 release(2013)80 cited
- → HBx regulates fatty acid oxidation to promote hepatocellular carcinoma survival during metabolic stress(2016)74 cited
- → Aldehyde dehydrogenase‐2 (ALDH2) opposes hepatocellular carcinoma progression by regulating AMP‐activated protein kinase signaling in mice(2016)74 cited
- → Targeting mTORC2/HDAC3 Inhibits Stemness of Liver Cancer Cells Against Glutamine Starvation(2022)71 cited
- → Blocking preferential glucose uptake sensitizes liver tumor-initiating cells to glucose restriction and sorafenib treatment(2016)62 cited